Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Chris1056on Nov 09, 2017 2:37pm
458 Views
Post# 26934768

RE:RE:RE:RE:Shorts

RE:RE:RE:RE:ShortsThanks Barcode. I mentioned a while back that the BOD must know something that we don't to keep PL in place. I worked many years with a BOD over my head, and if I was sharing publicly some predictions, I had to deliver. Otherwise, I would of been replaced. I love the scientific work of PL and is team, maybe the BOD also. I agree that through all those years PL didn't walk the talk. Can't wait on Tuesday to hear what he will say, and, I hope that the question period won't be cut off like on the last call. GLTA, Chris
Bullboard Posts